City faces dearth of key injections
City faces dearth of key injections City faces dearth of key injections ByVicky PathareVicky Pathare / Updated: Apr 21, 2021, 06:00 IST The shortage of Itolizumab may continue for 3-4 days After Remdesivir injection, the city is facing acute shortage of Tocilizumab and Itolizumab injections that are being used to treat COVID patients in severe conditions. Doctors consider both the drugs a crucial component in treatment for critically ill patients. While the demand for the drug continues to ri...
Rajesh Deshmukh Abhijit Lodha Drug Administration Hall Clinic Ruby Hall Clinic Food And Drug Administration
Source: indiatimes.com